Aaron Wealth Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Aaron Wealth Advisors's PFE Position: Q2 2026 in Review
Aaron Wealth Advisors reduced its Pfizer (PFE) stake by 8.8% in Q2 2026, selling an estimated $81K and leaving 32,183 shares worth $775K. The position accounts for 0.04% of the portfolio, ranked #309.
Aaron Wealth Advisors first reported a position in PFE in Q1 2022 and has held it in 18 quarters since. The position peaked at $1.03M in Q3 2025. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Aaron Wealth Advisors held 32,183 shares of Pfizer worth $775K as of Q2 2026.
- Aaron Wealth Advisors sold 3,097 Pfizer shares in Q2 2026, an estimated $81K.
- Pfizer made up 0.04% of Aaron Wealth Advisors's portfolio in Q2 2026, its #309 holding.
- Aaron Wealth Advisors first reported a position in Pfizer in Q1 2022 and has held it in 18 quarters since.
- Aaron Wealth Advisors's Pfizer position peaked at $1.03M in Q3 2025.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Aaron Wealth Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.